Alzheon
Alzheon is a biotech company in Framingham, United States, founded in 2013. It has raised $100.0M across 1 round, most recently a $100.0M Series E in June 2024.
Preserving future memories
- Headquarters
- Framingham, Massachusetts
- Founded
- 2013
- Website
- alzheon.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Series EJun 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Alzheon develops disease-modifying treatments for Alzheimer's disease and other neurodegenerative disorders by targeting protein misfolding and aggregation. Its investigational oral anti-amyloid treatment, valiltramiprosate/ALZ-801, recently completed Phase 3 testing in early symptomatic Alzheimer's disease.
Summary
It has raised $100.0M in total across 1 round, most recently a $100.0M Series E round in Jun 2024.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2024
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alzheon"><img src="https://indexed.vc/api/badge/company/alzheon" alt="Alzheon on Indexed.vc" width="260" height="76" /></a>

